Vascular involvement in Behçet's disease

Israel Medical Association Journal

Volumn 4, Issue 8, 2002, Pages 614-616

  Espinosa, Gerard ^a   Cervera, Ricard ^a   Reverter, Joan Carles ^a   Tàssies, Dolors ^a   Font, Josep ^a   Ingelmo, Miguel ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Activated coagulation factors; Behcet's disease; Thrombin generation; Thrombomodulin; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICOAGULANT AGENT; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5 LEIDEN; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN; STEROID; THROMBIN; THROMBOMODULIN;

ANEURYSM; ARTERY DISEASE; ARTERY OCCLUSION; ARTERY SURGERY; ARTERY THROMBOSIS; BEHCET DISEASE; BYPASS SURGERY; CLINICAL FEATURE; FIBRINOLYSIS; PATHOGENESIS; RELAPSE; REVIEW; THROMBOPHILIA; VASCULAR DISEASE; VEIN DISEASE; VEIN OCCLUSION; VEIN THROMBOSIS;

BEHCET SYNDROME; HUMANS; MUTATION; VASCULAR DISEASES;

EID: 0036341826     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. BD
2. BD
3. Criteria for diagnosis of Behçet's disease
4. Vascular involvement in BD: Arterial and venous and vessels of all sizes
5. Vascular involvement in BD
6. The repetitive vascular catastrophes of Behçet's disease. A case report with review of the literature
7. The ten-year mortality in Behçet's syndrome
8. Clinical manifestations of Behçet's disease: An analysis of 2147 patients
9. Thrombosis in behçet's disease: A retrospective survey from a single UK center
10. Vascular involvement in Behçet's disease: 8-year audit
11. Vena cava thrombosis in Behçet's disease. Analysis of a series of 10 cases
12. Budd-Chiari syndrome: A common complication of Behçet's disease
13. Cerebral venous thrombosis in Behçet's disease: Clinical study and long-term follow-up of 25 cases
14. Pulmonary arterial aneurysms in Behçet's syndrome
15. Vascular involvement in Behçet's Disease - A review of 129 cases
16. Cardiovascular manifestations of Behçet's disease
17. Right atrial and ventricular thrombi in Behçet's disease: A case report and review of the literature
18. Silent myocardial ischemia in Behçet's disease
19. Arterial lesions in Behçet's disease. A study in 25 patients
20. Negative antineutrophil cytoplasmic antibodies in Behçet's disease
21. Antibodies to endothelial cells in Behçet's disease: Cell binding heterogeneity and association with clinical activity
22. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease
23. Procoagulant mutations and venous thrombosis in Behçet's disease
24. Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease
25. Extensive venous thrombosis in a case of Behçet's disease associated with heterozygous protein C deficiency
26. Behçet syndrome associated with protein S deficiency
27. Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease
28. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothrombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease
29. Hyperhomocystenaemia and activated protein C resistance in Behçet's disease
30. Factor V Leiden mutation in patients with Behçet's disease
31. Association of factor V Leiden with Behçet's disease
32. 20210 mutation in Behçet's disease
33. Intracardiac thrombosis in a case of Behçet's disease associated with the prothrombin G20210A mutation
34. Absence of antiphospholipid antibodies in Behçet's disease
35. Anticardiolipin antibodies: Occurrence in Behçet's syndrome
36. Absence of lupus anticoagulant in Behçet's disease
37. Impaired haemostatic kinetics and endothelial function in Behçet's disease
38. Defective fibrinolysis in Behçet's syndrome: Significance and possible mechanisms
39. Vascular involvement in Behçet's disease: Relation with thrombophilic factors, coagulation activation, and thrombomodulin
40. The management of Behçet's syndrome